ArticleOncology research2026

Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma.

Xiaoxia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.